Condition

Non-Small Cell Lung Cancer

Treatments and trials tagged Non-Small Cell Lung Cancer, with the same country and access zoom as New Developments.

All New Developments

Non-Small Cell Lung Cancer breakthroughs

All countriesUnited StatesCanadaUnited KingdomJapanChinaAustraliaSwitzerlandEuropean UnionNewestPatient Stories
FDA ApprovedUnited States

New Pill for a Rare Gene-Related Lung Cancer

Jideytro (zidesamtinib) — oral ROS1 kinase inhibitor after a prior ROS1 TKI

On 22 July 2026 the FDA labelled Jideytro (zidesamtinib) tablets for adults with locally advanced or metastatic ROS1-positive NSCLC who…

Jideytro is a US-labelled oral pill for adults whose ROS1-positive lung cancer has already been treated with…

Health Canada/FDA ApprovedUnited StatesCanada

New Pill for a Gene-Related Advanced Lung Cancer

Hyrnuo (sevabertinib) for HER2 TKD-mutant NSCLC

The FDA and Health Canada have labelled an oral HER2 tyrosine-kinase inhibitor for adults with locally advanced or metastatic NSCLC whose tumours have HER2…

The FDA and Health Canada have labelled an oral HER2 tyrosine-kinase inhibitor for adults with locally…